Stock Track | GENSCRIPT BIO Plummets 5.54% Intraday on Profit-Taking After ASCO Rally and Sector Weakness

Stock Track
05/28

GENSCRIPT BIO's stock price plummeted 5.54% during intraday trading on Thursday, marking a significant reversal from its previous session's gains.

The decline appears to be driven by profit-taking activity following a rally in the prior session, which was catalyzed by positive research results from its associate company Legend Biotech at the ASCO annual meeting. Additionally, concerns over institutional selling have emerged, with Hong Kong Stock Connect channels experiencing consecutive days of significant net outflows prior to this session.

Broad weakness across the Life Sciences Tools & Services sector further pressured sentiment, with multiple major players in the space also trading lower during the session, contributing to the overall downward movement in GENSCRIPT BIO's share price.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10